The groundbreaking rise of Viagra has firmly established as a symbol of pharmaceutical success, yet its future within the broader industry now presents questions about long-term gains. Copycat versions are eroding exclusivity , prompting concerns that betting on companies significantly dependent to Viagra's once-dominant standing could be a specula